NCT00835081View on ClinicalTrials.gov

Cefadroxil 500 mg Capsules in Normal Healthy Non-Smoking Male and Female Subjects.

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
Healthy
Interventions
DRUG

Cefadroxil 500 mg Capsules

1 x 500 mg

DRUG

DURICEF® capsules 500 mg

1 x 500 mg

Trial Locations (2)

77099

Bioassay Laboratory, Inc., Houston

M1L 4R6

Biovail Contract Research, Toronto

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00835081 - Cefadroxil 500 mg Capsules in Normal Healthy Non-Smoking Male and Female Subjects. | Biotech Hunter | Biotech Hunter